A family of estimators to diagnostic accuracy when candidate tests are subject to detection limits—Application to diagnosing early stage Alzheimer disease. (May 2022)
- Record Type:
- Journal Article
- Title:
- A family of estimators to diagnostic accuracy when candidate tests are subject to detection limits—Application to diagnosing early stage Alzheimer disease. (May 2022)
- Main Title:
- A family of estimators to diagnostic accuracy when candidate tests are subject to detection limits—Application to diagnosing early stage Alzheimer disease
- Authors:
- Xiong, Chengjie
Luo, Jingqin
Agboola, Folasade
Grant, Elizabeth
Morris, John C. - Abstract:
- In disease diagnosis, individuals are usually assumed to be one of the two basic types, healthy or diseased, as typically based on an established gold standard. Candidate markers for diagnosing a disease often are much cheaper and less invasive than the gold standard but must be evaluated against the gold standard for their sensitivity and specificity to accurately diagnose the disease. When candidate diagnostic markers are fully measured, receiver operating characteristic curves have been the standard approaches for assessing diagnostic accuracy. However, full measurements of diagnostic markers may not be available above or below certain limits due to various practical and technical limitations. For example, in the diagnosis of Alzheimer disease using cerebrospinal fluid biomarkers, the Roche Elecsys® immunoassays have a measuring range for multiple cerebrospinal fluid molecular concentrations. Many cognitive tests used in diagnosing dementia due to Alzheimer disease are also subject to detection limits, often referred to as the floor and ceiling effects in the neuropsychological literature. We propose a new statistical methodology for estimating the diagnostic accuracy when a diagnostic marker is subject to detection limits by dividing the entire study sample into two sub-samples by a threshold of the diagnostic marker. We then propose a family of estimators to the area under the receiver operating characteristic curve by combining a conditional nonparametric estimator andIn disease diagnosis, individuals are usually assumed to be one of the two basic types, healthy or diseased, as typically based on an established gold standard. Candidate markers for diagnosing a disease often are much cheaper and less invasive than the gold standard but must be evaluated against the gold standard for their sensitivity and specificity to accurately diagnose the disease. When candidate diagnostic markers are fully measured, receiver operating characteristic curves have been the standard approaches for assessing diagnostic accuracy. However, full measurements of diagnostic markers may not be available above or below certain limits due to various practical and technical limitations. For example, in the diagnosis of Alzheimer disease using cerebrospinal fluid biomarkers, the Roche Elecsys® immunoassays have a measuring range for multiple cerebrospinal fluid molecular concentrations. Many cognitive tests used in diagnosing dementia due to Alzheimer disease are also subject to detection limits, often referred to as the floor and ceiling effects in the neuropsychological literature. We propose a new statistical methodology for estimating the diagnostic accuracy when a diagnostic marker is subject to detection limits by dividing the entire study sample into two sub-samples by a threshold of the diagnostic marker. We then propose a family of estimators to the area under the receiver operating characteristic curve by combining a conditional nonparametric estimator and another conditional semi-parametric estimator derived from Cox's proportional hazards model. We derive the variance to the proposed estimators, and further, assess the performance of the proposed estimators as a function of possible thresholds through an extensive simulation study, and recommend the optimum thresholds. Finally, we apply the proposed methodology to assess the ability of several cerebrospinal fluid biomarkers and cognitive tests in diagnosing early stage Alzheimer disease dementia. … (more)
- Is Part Of:
- Statistical methods in medical research. Volume 31:Number 5(2022)
- Journal:
- Statistical methods in medical research
- Issue:
- Volume 31:Number 5(2022)
- Issue Display:
- Volume 31, Issue 5 (2022)
- Year:
- 2022
- Volume:
- 31
- Issue:
- 5
- Issue Sort Value:
- 2022-0031-0005-0000
- Page Start:
- 882
- Page End:
- 898
- Publication Date:
- 2022-05
- Subjects:
- Alzheimer disease -- area under the receiver operating characteristic curve -- bootstrap -- confidence interval estimate -- Cox proportional hazards model -- detection limits -- diagnostic accuracy -- maximum likelihood estimate -- nonparametric estimate -- receiver operating characteristic curve
Medicine -- Research -- Statistical methods -- Periodicals
Research -- Periodicals
Review Literature -- Periodicals
Statistics -- methods -- Periodicals
Médecine -- Recherche -- Méthodes statistiques -- Périodiques
610.727 - Journal URLs:
- http://smm.sagepub.com/ ↗
http://www.ingentaselect.com/rpsv/cw/arn/09622802/contp1.htm ↗
http://www.uk.sagepub.com/home.nav ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0962-2802;screen=info;ECOIP ↗ - DOI:
- 10.1177/09622802211072511 ↗
- Languages:
- English
- ISSNs:
- 0962-2802
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 20078.xml